Hillstar Bio | $67,000,000 | (Apr 2, 2025)
Sympera AI | $10,000,000 | (Apr 2, 2025)
LTV.ai | $5,200,000 | (Apr 2, 2025)
Certified by Founder
Lodge
Clarametyx Biosciences
start up
United States
- Columbus, Ohio
- 08/01/2024
- Series A
- $33,000,000
Clarametyx Biosciences Inc. is a clinical stage biotechnology company developing immune-enabling biologic therapies to fight life-threatening infections. Our novel technology platform targets the protective barrier around bacteria, known as biofilms.
- Industry Biotechnology Research
- Website https://clarametyx.com/
- LinkedIn https://www.linkedin.com/company/clarametyx-biosciences/about/
Related People
David V. RichardsFounder
United States -
Columbus, Ohio
Life sciences executive and entrepreneur with a passion for building transformative science into compelling companies. Focus on high patient need categories that hold the potential for broad impact on national and global health, with a personal interest in infectious disease, neurocognitive and genetic disorders.
Sturdy | $6,000,000 | (Apr 2, 2025)
Tomorro | $26,995,875 | (Apr 2, 2025)
InfiniLink | $10,000,000 | (Apr 2, 2025)
voize | $9,000,000 | (Apr 2, 2025)
EVident Battery, Inc. | $3,200,000 | (Apr 2, 2025)
Notable Systems | $12,000,000 | (Apr 2, 2025)
LightSource | $33,000,000 | (Apr 2, 2025)
Atomic(US) | $10,000,000 | (Apr 2, 2025)
ControlTheory | $5,000,000 | (Apr 2, 2025)